17/02/2023 (Agence Europe) – The European Medicines Agency (EMA) on Thursday 16 February published an overview of its work on medicines for human use for 2022. In 2022, the EMA recommended to the European Commission that 89 new medicines for human use in various areas of medicine be granted a European marketing authorisation. 41 of these medicines contained a new active substance that has not yet been granted a European marketing authorisation. In addition, the EMA recommended 21 orphan medicines. The EMA provides details of its recommendations for vaccines to protect citizens against Covid-19, treatments for this disease and vaccines against mpox, previously known as ‘monkeypox’. The EMA reports on other activities such as pharmacovigilance, the Emergency Task Force and international cooperation. More info at: https://aeur.eu/f/5e9 (EV)